SEC Form 4 · accession 0001192482-16-000773
Aevi Genomic Medicine, Inc. · GNMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph J Grano Jr.
Director
Period of report
Dec 8, 2016
Accepted (ET)
Dec 12, 2016 · 5:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001138776
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 8, 2016 | P | 3,000 | $5.266 | D | 58,780 | D | |
| Common StockF2 | holding | — | — | — | 15,384 | I | By: Family Foundation |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported represents the weighted average purchase price of the shares purchased. The shares were purchased at varying prices in the range of $5.265 to $5.27. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price.
- F2By the Grano Family Foundation.